HIV Flashcards

(52 cards)

1
Q

what is HIV

A

depletion CD4 lymphocytes- progressive immunosuppression, susceptibility to opportunistic infections and cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is HIV

A

depletion CD4 lymphocytes- progressive immunosuppression, susceptibility to opportunistic infections and cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

when does seroconversion occur

A

2-4 weeks after infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what CD4 is when AIDs occurs

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

where does HIV bind

A

via gp120 glycoprotein to CD4 receptors on T helper, monocytes, macrophages, neural cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

signs seroconversion

A

primary infection. transient illness. fever, malaise, myalgia, pharyngitis, maculopapular rash, meningoencephalitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what follows seroconversion

A

asymptomatic infection. 30% have persistent generalised lymphadenopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

definition of AIDs

A

HIV + indicator of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

definition of AIDs

A

HIV + indicator of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

when does seroconversion occur

A

2-4 weeks after infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what CD4 is when AIDs occurs

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

where does HIV bind

A

via gp120 glycoprotein to CD4 receptors on T helper, monocytes, macrophages, neural cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

If recent infection what tests can be done (if HIV Ab -ve)

A

HIV RNA or core p24 antigen; or check at 6 weeks and 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what follows seroconversion

A

asymptomatic infection. 30% have persistent generalised lymphadenopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

first line treatment TB

A

isoniazid, pyrazinamide, rifampicin, ethambutol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

definition of AIDs

A

HIV + indicator of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

time scale HIV to AIDs

A

8 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

timescale ARC to AIDs

A

2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

time scale AIDs to death

A

2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

diagnosis

A

serum or salivary HIV-Ab by ELISA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

other pathogens affecting lungs in HIV

A

M avium intracellulare, CMV,HHV8 (Kaposis sarcoma), lymphoid intersititial pneumonitis

22
Q

in patient who is HIV +ve and cough, fever, night sweats, weight loss what is it until proven otherwise

23
Q

first line treatment TB

A

isoniazid, pyrazinamide, rifampicin, ethambutol

24
Q

treatment CMV retinitis

A

ganciclovir containing intra ocular implants

25
CNS complications
acute- transient menongoencaphelitis, myelopathy, neuropathy. chronic- dementia, encephalopathy
26
treatment pneumocystis jiroveci
co trimoxazole
27
diagnosis pneumocystis jiroveci
sputum or bronchoscopy and bronchoalveolar lavage
28
primary prophylaxis pneumocystis jiroveci
if CD4
29
other pathogens affecting lungs in HIV
M avium intracellulare, CMV,HHV8 (Kaposis sarcoma), lymphoid intersititial pneumonitis
30
gut complications
candidiasis, HSV, aphthous ulcers, tumous, oesophageal dysphagia and retrosternal discomfort, anorexia, incr LFTs, hepatosplenomegaly, chronic diarrhoea, perianal disease, Kaposis sarcoma, lymphoma
31
eye complications
CMV retinitis- fundoscopy- mozzarella pizza signs
32
PEP
Truvada tab, 2 Kaleta tabs
33
CNS complications
acute- transient menongoencaphelitis, myelopathy, neuropathy. chronic- dementia, encephalopathy
34
indications for beginning antiretroviral therapy
CD4 200; pregnant women; if co infected with hep B and having treatment for hep B
35
treatment toxoplasmosis
pyrimethamine
36
benefits of earlier anti retrovirals
preservation immune function, prolonged survival, fewer adverse events, decreased transmission
37
when should you start PEP
48-72hours after
38
how long should PEP be given
28 days (4 weeks)
39
follow up with PEP
12 and 24 weeks
40
PEP
Truvada tab, 2 Kaleta tabs
41
typical regimen for HIV1
efavirenz with 2 NRTIs- lamivudine and tenofovir disoproxil fumarate
42
indications for beginning antiretroviral therapy
CD4 200; pregnant women; if co infected with hep B and having treatment for hep B
43
potential risks of earlier anti retrovirals
drug toxicity, drug resistance, exhaustion of drug options
44
benefits of earlier anti retrovirals
preservation immune function, prolonged survival, fewer adverse events, decreased transmission
45
which virus is responsible for most HIV infections
HIV1
46
what are the main classes of antiretrovirals
NRTIs (nucleoside reverse transcriptase inhibitor), PIs (protease inhibitor), NNRTIs (non nucleoside reverse transcriptase inhibitors)
47
what can is HAART and what can it cause
highly active antiretroviral therapy- renal failure and insulin resistance
48
what can PIs and NNRTIs interact with
drugs metabolised by cytochrome p450
49
typical regimen for HIV1
efavirenz with 2 NRTIs- lamivudine and tenofovir disoproxil fumarate
50
example of NRTI
tenofevir, lamivudine, zidovudine
51
example PI
lopinavir
52
example NNRTI
efavirenz